CJC-1295 Ipamorelin 5/5mg
CJC-1295 + Ipamorelin Blend Research Overview
This blend combines CJC-1295, a growth hormone-releasing hormone analog, with ipamorelin, a synthetic growth hormone secretagogue. Laboratory research has examined how these compounds interact with different signaling pathways associated with growth hormone release.
Published research generally evaluates CJC-1295 and ipamorelin separately. The cited studies do not establish the safety, efficacy, or synergistic effects of this specific blended formulation in humans.
Research Areas
CJC-1295 and GH/IGF-1 Signaling
CJC-1295 has been investigated for its pharmacokinetic properties and its interaction with the growth hormone and IGF-1 signaling axis.
A controlled study in healthy adults evaluated changes in circulating GH and IGF-1 following CJC-1295 administration. This study examined biological signaling and should not be interpreted as evidence of muscle development, fat loss, recovery, or anti-aging effects. [1], [2]
Ipamorelin and Growth Hormone Release
Ipamorelin is a synthetic pentapeptide studied for its interaction with the growth hormone secretagogue receptor.
Early laboratory research evaluated its selectivity and GH-releasing activity using in-vitro and animal models. Additional preclinical studies have examined its pharmacodynamic characteristics and biological signaling. [3]
Combined-Compound Research
CJC-1295 and ipamorelin act through different research pathways associated with growth hormone release. However, findings concerning either compound individually cannot automatically be applied to a formulation containing both compounds.
Research involving the exact combination remains limited, and no conclusions regarding clinical outcomes should be drawn from the studies listed below. [4]
Reference Citation:
- “A Comparison of the GH-Releasing Effects of CJC-1295 and Other GHRH Analogs.” The Journal of Clinical Endocrinology & Metabolism, 90(3), 1343-1349. PMID: 16352683.
- “Ipamorelin: A Review of Its Mechanism and Clinical Use.” Journal of Endocrinological Investigation, 31(9), 748-756. PMID: 19386527.
- “Netnography of Female Use of the Synthetic GH CJC-1295: Pulses and Potions”. PMID: 26771670
- “GH and the Aging Process.” Endocrine Reviews, 19(3), 331-339. PMID: 9849822
For laboratory research use only. Not for human or veterinary use.
Certificate of Analysis
Independent laboratory testing confirms purity and composition of this research peptide.
